Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
AstraZeneca
Express Scripts
Medtronic
Farmers Insurance
Citi
Fish and Richardson
Queensland Health
Johnson and Johnson
Harvard Business School

Generated: August 17, 2017

DrugPatentWatch Database Preview

HYDROCHLOROTHIAZIDE W/ RESERPINE Drug Profile

« Back to Dashboard

Which patents cover Hydrochlorothiazide W/ Reserpine, and when can generic versions of Hydrochlorothiazide W/ Reserpine launch?

Hydrochlorothiazide W/ Reserpine is a drug marketed by Roxane, Watson Labs, Pharmeral, and Ivax Sub Teva Pharms. and is included in fourteen NDAs.

The generic ingredient in HYDROCHLOROTHIAZIDE W/ RESERPINE is hydralazine hydrochloride; hydrochlorothiazide; reserpine. There are nineteen drug master file entries for this compound. Additional details are available on the hydralazine hydrochloride; hydrochlorothiazide; reserpine profile page.

Summary for Tradename: HYDROCHLOROTHIAZIDE W/ RESERPINE

Patents:0
Applicants:4
NDAs:14
Bulk Api Vendors: see list47
Clinical Trials: see list318
Patent Applications: see list8
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:HYDROCHLOROTHIAZIDE W/ RESERPINE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roxane
HYDROCHLOROTHIAZIDE W/ RESERPINE
hydrochlorothiazide; reserpine
TABLET;ORAL084603-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
HYDROCHLOROTHIAZIDE W/ RESERPINE
hydrochlorothiazide; reserpine
TABLET;ORAL084466-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharmeral
HYDROCHLOROTHIAZIDE W/ RESERPINE
hydrochlorothiazide; reserpine
TABLET;ORAL085421-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Ivax Sub Teva Pharms
HYDROCHLOROTHIAZIDE W/ RESERPINE
hydrochlorothiazide; reserpine
TABLET;ORAL083572-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
HYDROCHLOROTHIAZIDE W/ RESERPINE
hydrochlorothiazide; reserpine
TABLET;ORAL083666-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Novartis
Deloitte
Medtronic
US Department of Justice
Covington
Accenture
Cantor Fitzgerald
Johnson and Johnson
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot